Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata
- 1 January 1996
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 34 (1) , 58-61
- https://doi.org/10.1128/jcm.34.1.58-61.1996
Abstract
CHROMagar Candida is a new differential culture medium that allows selective isolation of yeasts and simultaneously identifies colonies of Candida albicans, C. tropicalis, and C. krusei. We evaluated the use of this medium with 316 yeast isolates including 247 isolated directly on CHROMagar from clinical material. Over 95% of stock and clinical isolates of C. albicans, C. tropicalis, and C. krusei were correctly identified on the basis of colony morphology and pigmentation on CHROMagar. Additionally, CHROMagar also allowed the identification of C. (Torulopsis) glabrata at a similar level of accuracy. The overall agreement between two observers in reading the CHROMagar plates was 95%. Growth of Candida sp. isolates on CHROMagar had no adverse effect on antifungal MICs or Vitek identification results. In parallel, cultures of 548 stool and rectal swab specimens set up on CHROMagar and Sabouraud glucose agar (SGA) were positive in 234 instances. CHROMagar was positive and SGA was negative for 11 specimens, and CHROMagar was negative and SGA was positive for 18 specimens. A single yeast species was isolated on both media from 162 specimens, and in 146 (90%) of these specimens the same species was detected on both CHROMagar and SGA. A total of 43 of the 234 positive cultures contained mixtures of yeast species. Twenty (47%) of these mixed cultures were detected only on CHROMagar. CHROMagar is extremely useful in making a rapid presumptive identification of common yeast species. This capability plus the ability to detect mixed cultures of Candida spp. promises to improve and streamline the work flow in the mycology and clinical microbiology laboratory.Keywords
This publication has 9 references indexed in Scilit:
- Epidemiology of candidiasisJournal of Hospital Infection, 1995
- Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870Journal of Clinical Microbiology, 1995
- Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupAntimicrobial Agents and Chemotherapy, 1995
- Importance of Candida Species Other than C. albicans as Pathogens in Oncology PatientsClinical Infectious Diseases, 1995
- CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida speciesJournal of Clinical Microbiology, 1994
- Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year periodAntimicrobial Agents and Chemotherapy, 1994
- Investigation of the sequence of colonization and candidemia in nonneutropenic patientsJournal of Clinical Microbiology, 1994
- Predictive value of surveillance cultures for systemic infection due toCandida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal InfectionsThe Journal of Infectious Diseases, 1980